Prevalence of Dyslipidemia and Lipid Goal Attainment in Statin‐Treated Subjects From 3 Data Sources: A Retrospective Analysis
Open Access
- 29 November 2012
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Journal of the American Heart Association
- Vol. 1 (6), e001800
- https://doi.org/10.1161/jaha.112.001800
Abstract
Background Evidence‐based randomized clinical trials have shown significant benefit of statin treatment with regard to cardiovascular disease. In anticipation of the National Cholesterol Education Program Adult Treatment Panel IV guidelines, we wanted to assess the current state of lipid goal attainment in the high‐risk secondary prevention population in the United States. The objectives of the study were to estimate the proportion of high‐risk patients treated with statin monotherapy who achieved Adult Treatment Panel III–recommended low‐density lipoprotein cholesterol ( LDL‐C ) goals (90 days at the time of the lipid panel. Cardiovascular disease, coronary heart disease, and coronary heart disease risk equivalents were defined on the basis of availability, specific to each data source. Across the 3 data sources, 20% to 26% of high‐risk patients treated with statin monotherapy for >90 days had LDL‐C <70 mg/dL, and 67% to 77% had LDL‐C <100 mg/dL. The percentages of those attaining both LDL‐C goals and non–high‐density lipoprotein cholesterol goals were quantitatively smaller (13.5% to 19.0% and 46% to 70%). Conclusions Across the 3 data sources, there was consistency in the proportion of high‐risk patients treated with statin monotherapy who were at LDL‐C goal. A significant number of these statin‐treated patients had additional dyslipidemias.This publication has 32 references indexed in Scilit:
- Institutional, provider, and patient correlates of low-density lipoprotein and non–high-density lipoprotein cholesterol goal attainment according to the Adult Treatment Panel III guidelinesAmerican Heart Journal, 2011
- Trends in utilization of lipid- and blood pressure-lowering agents and goal attainment among the U.S. diabetic population, 1999-2008Cardiovascular Diabetology, 2011
- ‘Trig-onometry’: non-high-density lipoprotein cholesterol as a therapeutic target in dyslipidaemiaInternational Journal of Clinical Practice, 2010
- 30-Year Trends in Serum Lipids Among United States Adults: Results from the National Health and Nutrition Examination Surveys II, III, and 1999–2006The American Journal of Cardiology, 2010
- Prevalence and overlap of different lipid abnormalities in statin-treated patients at high cardiovascular risk in clinical practice in GermanyClinical Research in Cardiology, 2010
- Adherence and chemoprevention in major cardiovascular disease: a simulation study of the benefits of additional use of statinsJournal of Epidemiology and Community Health, 2010
- Frequency of Obtaining National Cholesterol Education Program Adult Treatment Panel III Goals for All Major Serum Lipoproteins After Initiation of Lipid Altering TherapyThe American Journal of Cardiology, 2009
- Major Lipids, Apolipoproteins, and Risk of Vascular DiseaseJAMA, 2009
- Current status of cholesterol goal attainment after statin therapy among patients with hypercholesterolemia in Asian countries and region: the Return on Expenditure Achieved for Lipid Therapy in Asia (REALITY-Asia) studyCurrent Medical Research and Opinion, 2008
- Results of the National Cholesterol Education (NCEP) Program Evaluation Project Utilizing Novel E-Technology (NEPTUNE) II Survey and Implications for Treatment Under the Recent NCEP Writing Group RecommendationsThe American Journal of Cardiology, 2005